LLY compared with AQST: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

AQSTAquestive Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

AQSTAquestive Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

AQST

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±12.6%▼−2.06%×0.17

Q2 FY26±12.4%▼−4.08%×0.33

= impliedLLY realized, solidAQST realized, hatchedOne scale, both sides: full bar = 15%× = |realized| ÷ impliedSource: market data

May 14 '26

±7.7%

▲+14.53%

×1.88

Q1 FY26±14.1%▼−2.52%×0.18

LLYELI Lilly & Co

1,362.66▼−0.15%

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

AQSTAquestive Therapeutics, Inc.

3.66▼−0.07%

Regular sessionNov 6 '26

Mkt cap$460.0MRevenue$8MQ3 FY26Revenue$45MFY25

Compare

Regular sessionNov 6 '26

LLYELI Lilly & Co

AQSTAquestive Therapeutics, Inc.

1,362.66▼−0.15%

Price

3.66▼−0.07%

$1.2T

Mkt cap

$460.0M

Q3 FY26$24.4B

Revenue

$8MQ3 FY26

FY25$65.2B

Revenue

$45MFY25

LLY1,362.66▼−0.15%vsAQST3.66▼−0.07%Regular sessionNov 6 '26